Avadel Pharmaceuticals plc

Direct answer

Avadel Pharmaceuticals plc is publicly traded on NASDAQ under the ticker AVDL.

Avadel Pharmaceuticals plc is a biopharmaceutical firm primarily conducting its operations within the United States. The company's flagship investigational drug, FT218, a specialized compound of sodium oxybate, is currently in Phase 3 clinical trials. This therapeutic candidate aims to alleviate severe daytime somnolence and sudden muscle weakness (cataplexy) in adult individuals afflicted with narcolepsy....

Can you invest in Avadel Pharmaceuticals plc?

Yes. Avadel Pharmaceuticals plc trades publicly on NASDAQ as AVDL.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Avadel Pharmaceuticals plc

Detailed equity research is provided by MarketSnap.